Impaired imipenem uptake associated with alterations in outer membrane proteins and lipopolysaccharides in imipenem-resistant Shigella dysenteriae

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 2, 1999, Pages 195-201

  Ghosh, Anindya Sundar ^a   Kar, Alak Kanti ^a   Kundu, Manikuntala ^a  

^a BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEOXY MANNO OCTULOSONIC ACID; AMOXICILLIN; AMPICILLIN; BACTERIUM LIPOPOLYSACCHARIDE; BETA LACTAM ANTIBIOTIC; CEFALORIDINE; CEFOPERAZONE; CIPROFLOXACIN; IMIPENEM; LATAMOXEF; NITROCEFIN; OUTER MEMBRANE PROTEIN; PENICILLIN BINDING PROTEIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM MUTANT; DRUG UPTAKE; MEMBRANE PERMEABILITY; NONHUMAN; SHIGELLA DYSENTERIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CARRIER PROTEINS; DRUG RESISTANCE, MICROBIAL; HEXOSYLTRANSFERASES; IMIPENEM; LIPOPOLYSACCHARIDES; MICROBIAL SENSITIVITY TESTS; MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; MUTATION; PENICILLIN-BINDING PROTEINS; PEPTIDYL TRANSFERASES; SHIGELLA DYSENTERIAE; THIENAMYCINS;

EID: 0033031973     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.2.195     Document Type: Article

References (30)

1. Bennish, M. L., Harris, J. R., Wojtyniak, B. J. & Struelens, M. (1990). Death in shigellosis: incidence and risk factors in hospitalized patients. Journal of Infectious Diseases 161, 500-6.
2. Bennish, M. L. & Salam, M. A. (1992). Rethinking options for the treatment of shigellosis. Journal of Antimicrobial Chemotherapy 30, 243-7.
3. Bradford, P. A., Urban, C., Mariano, N., Projan, S. J., Rahal, J. J. & Bush, K. (1997). Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrobial Agents and Chemotherapy 41, 563-9.
4. Trias, J. & Nikaido, H. (1990). Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 34, 52-7.
5. Raimondi, A., Traverso, A. & Nikaido, H. (1991). Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins. Antimicrobial Agents and Chemotherapy 35, 1174-80.
6. Kar, A. K., Ghosh, A. S., Chauhan, K., Ahamed, J., Basu, J., Chakrabarti, P. et al. (1997). Involvement of a 43-kilodalton outer membrane protein in β-lactam resistance of Shigella dysenteriae. Antimicrobial Agents and Chemotherapy 41, 2302-4.
7. Mahapatra, S., Basu, J., van Beeumen, J. & Kundu, M. (1994). Characterization of a 38 kDa penicillin-binding protein and its possible involvement in maintaining stationary-phase cells of Shigella dysenteriae. Microbiology 140, 3177-82.
8. O'Callaghan, C. H., Morris, A., Kirby, S. M. & Shingler, A. H. (1972). Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrobial Agents and Chemotherapy 1, 283-88.
9. Toney, J. H., Wu, J. K., Overbye, K. M., Thompson, C. M. & Pompliano, D. L. (1997). High-yield expression, purification, and characterization of active, soluble Bacteroides fragilis metallo-β-lactamase, CcrA. Protein Expression and Purification 9, 355-62.
10. Pham, J. N. & Bell, S. M. (1992) β-Lactamase induction by imipenemin Yersinia enterocolitica. Pathology 24, 201-4.
11. Nikaido, H. & Rosenberg, E. Y. (1983). Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins. Journal of Bacteriology 153, 241-52.
12. Nikaido, H., Rosenberg, E. Y. & Foulds, J. (1983). Porin channels in Escherichia coli: studies with β-lactams in intact cells. Journal of Bacteriology 153, 232-40.
13. Yoshimura, F. & Nikaido, H. (1985). Diffusion of β-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrobial Agents and Chemotherapy 27, 84-92.
14. Westphal, O. & Jann, K. (1965). Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. Methods in Carbohydrate Chemistry 5, 83-91.
15. Hitchcock, P. J. & Brown, T. M. (1983). Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. Journal of Bacteriology 154, 269-77.
16. Karkhanis, Y. D., Zeltner, J. Y., Jackson, J. J. & Carlo, D. J. (1978). A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Analytical Biochemistry 85, 595-601.
17. Nikaido, H. & Rosenberg, E. Y. (1981). Effect of solute size on diffusion rates through the transmembrane pores of the outer membrane of Escherichia coli. Journal of General Physiology 77, 121-35.
18. Lindberg, A. A., Karnell, A. & Weintraub, A. (1991). The lipopolysaccharide of Shigella bacteria as a virulence factor. Reviews of Infectious Diseases 13, Suppl. 4, 279-84.
19. Jenkinson, H. F. (1996). In and outs of antimicrobial resistance: era of the drug pumps. Journal of Dental Research 75, 736-42.
20. Paulsen, I. T., Brown, M. H. & Skurray, R. A. (1996). Proton-dependent multidrug efflux systems. Microbiological Reviews 60, 575-608.
21. Nakae, T. (1995). Role of membrane permeability in determining antibiotic resistance in Pseudomonas aeruginosa. Microbiology and Immunology 39, 221-9.
22. Tzouvelekis, L. S., Tzelepi, E., Kaufmann, M. E. & Mentis, A. F. (1994). Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes Journal of Medical Microbiology 40, 403-7.
23. Martinez-Martinez, L., Hernandez-Alles, S., Alberti, S., Tomas, J. M., Benedi, V. J. & Jacoby, G. A. (1996). In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 40, 342-8.
24. De Cock, H. & Tommassen, J. (1996). Lipopolysaccharides and divalent cations are involved in the formation of an assembly-competent intermediate of outer-membrane protein PhoE of E. coli. EMBO Journal 15, 5567-73.
25. Sen, K. & Nikaido, H. (1991). Lipopolysaccharide structure required for in vitro trimerisation of Escherichia coli OmpF porin. Journal of Bacteriology 173, 926-8.
26. Wilkinson, S. G. (1996). Bacterial lipopolysaccharides -themes and variations. Progress in Lipid Research 35, 283-343.
27. Angus, B. L., Carey, A. M., Caron, D. A., Kropinski, A. M. & Hancock, R. E. (1982). Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrobial Agents and Chemotherapy 21, 299-309.
28. Ishii, J. & Nakae, T. (1993). Lipopolysaccharide promoted opening of the porin channel. FEBS Letters 320, 251-5.
29. Rajyaguru, J. M. & Muszynski, M. J. (1997). Association of resistance to trimethoprim/sulphamethoxazole, chloramphenicol and quinolones with changes in major outer membrane proteins and lipopolysaccharide in Burkholderia cepacia. Journal of Antimicrobial Chemotherapy 40, 803-9.
30. Leying, H., Cullmann, W. & Dick, W. (1991). Carbapenem resistance in Enterobacter aerogenes is due to lipopolysaccharide alterations. Chemotherapy 37, 106-13.